Capilitan, Jelly Be .

HRN: 03-02-87  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2026
CO-AMOXICLAV 625MG (TAB)
06/02/2026
06/09/2026
PO
625MG
BID
NKA
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines